<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="69173">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02205307</url>
  </required_header>
  <id_info>
    <org_study_id>PP PLR 03</org_study_id>
    <nct_id>NCT02205307</nct_id>
  </id_info>
  <brief_title>A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection</brief_title>
  <acronym>PILLAR III</acronym>
  <official_title>A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novadaq Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novadaq Technologies Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, parallel, multicenter study to determine the difference in
      post-operative anastomotic leak rate in low anterior resection procedures where colon and
      rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical
      practice compared to surgical procedures performed according to standard surgical practice
      alone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic Leak Rate</measure>
    <time_frame>Day 0 to Week 8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the ability of PINPOINT or SPY Elite to provide sufficient visualization for assessment of blood flow and related tissue perfusion during the procedure</measure>
    <time_frame>Day 0 to Week 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of postoperative abscess requiring surgical management</measure>
    <time_frame>Day 0 to Week 8</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Rectosigmoid Cancer</condition>
  <arm_group>
    <arm_group_label>PINPOINT or SPY Elite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A low anterior resection will be performed according to the surgeon's standard practice with the addition of intraoperative imaging using PINPOINT near infrared fluorescence imaging or SPY Elite intraoperative imaging to assess colon and rectal tissue perfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STANDARD</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>A low anterior resection will be performed according to the surgeon's standard practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PINPOINT</intervention_name>
    <arm_group_label>PINPOINT or SPY Elite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SPY Elite</intervention_name>
    <arm_group_label>PINPOINT or SPY Elite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be 18 years of age or older.

          -  Be undergoing open, or minimally invasive LAR for the treatment of a rectal or
             rectosigmoid neoplasm (Subjects with rectal or rectosigmoid neoplasm(s) may be
             treated with or without neoadjuvant therapy. Long-course neoadjuvant therapy must
             have been completed ≥6 weeks prior to LAR surgery (Day 0).

          -  Have a planned low circular stapled or transanally hand sewn anastomosis ≤10 cm from
             the anal verge.

          -  Have a colorectal or coloanal reconstruction with or without reservoir/pouch.

          -  Subjects who are women of child-bearing potential must not be pregnant or lactating,
             must have a negative pregnancy test at Day 0.

          -  Have signed an approved informed consent form for the study.

          -  Be willing to comply with the protocol.

        Exclusion Criteria:

          -  Undergoing stapled anastomosis with the use of an experimental or non-FDA approved
             stapler.

          -  Undergoing ileoanal reconstruction, total colectomy or proctocolectomy,
             abdominoperineal resection, Hartmann's procedure, Hartmann's reversal or multiple
             synchronous colon resections (e.g., LAR and concomitant right colectomy).

          -  Has received and completed a course of pelvic radiotherapy ≥ 6 months prior to LAR
             surgery (Day 0).

          -  Has previously undergone a left sided colon resection.

          -  Has previously undergone a rectal resection.

          -  Has recurrent rectal or rectosigmoid cancer.

          -  Has a diagnosis of locally advanced rectal or rectosigmoid cancer undergoing extended
             en bloc operations.

          -  Has a diagnosis of Stage IV rectal or rectosigmoid cancer with any multifocal
             metastases or single site metastasis with tumor size of &gt; 2 cm (Intraoperative
             incidental finding or preoperative suspicion of Stage IV cancer with isolated (single
             site) metastasis (≤ 2 cm) or limited metastases (≤3), with largest lesion ≤ 2 cm in
             size, does not exclude the subject).

          -  Has a diagnosis of inflammatory bowel disease (IBD). Subjects with rectal or
             rectosigmoid cancer neoplasms and IBD are excluded.

          -  Has hepatic dysfunction defined as Model for End-Stage Liver Disease (MELD) Score
             &gt;12.

          -  Renal dysfunction defined as creatinine ≥ 2.0 mg/dL.

          -  Has known allergy or history of adverse reaction to ICG, iodine or iodine dyes.

          -  Has, in the Investigator's opinion, any medical condition that makes the subject a
             poor candidate for the investigational procedure, or interferes with the
             interpretation of study results.

          -  Is actively participating in another investigational clinical study which, in the
             Investigator's or Sponsor's opinion, would interfere in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Stamos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Wexner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alicia Wilton</last_name>
    <phone>905-629-3822</phone>
    <phone_ext>209</phone_ext>
    <email>awilton@novadaq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vasanthi Govindaraju, PhD</last_name>
    <phone>443-794-4460</phone>
    <email>ecoolidge@novadaq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John Muir Medical Center, Concord Campus</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Newsom</last_name>
      <email>peggy.newsom@johnmuirhealth.com</email>
    </contact>
    <investigator>
      <last_name>Negar Salehomoum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Baker-Bolden, RN</last_name>
      <email>sandra.t.baker@kp.org</email>
    </contact>
    <investigator>
      <last_name>Elisabeth McLemore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Irvine</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Chavez, MD, CCRP</last_name>
      <email>chavezc@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Alessio Pigazzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Rhee</last_name>
      <email>Jessica.rhee@ucsfmedctr.org</email>
    </contact>
    <investigator>
      <last_name>Madhulika Varma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauricia Buchanan, RN, BSN</last_name>
      <email>buchanan.mauricia@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Ron Landman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Karlnoski, PhD</last_name>
      <email>rkarlnos@hsc.usf.edu</email>
    </contact>
    <investigator>
      <last_name>Sowsan Rasheid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Mejia, BSc</last_name>
      <email>mejiagm@ccf.org</email>
    </contact>
    <investigator>
      <last_name>David Maron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Ohara</last_name>
      <email>Karen_Ohara@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Singer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryanne Bowyer, RN</last_name>
      <email>mbowyer@iupui.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jean Lonergan, RN</last_name>
      <email>jeanlone@iupui.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alyssa Fajardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Green</last_name>
      <email>hgreen@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>David Margolin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Obichukwu Ezennia</last_name>
      <email>oezenni1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Bashar Safar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lieba Savitt, NP-C, RN-C, MSN</last_name>
      <email>LSAVITT@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Liliana Bordeianou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Medical Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Cusumano, RN, BSN</last_name>
      <email>cusumanom@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Mutch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunrise Hospital and Medical Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Moore, MA</last_name>
      <phone>702-671-6421</phone>
      <email>samoore@medicine.nevada.edu</email>
    </contact>
    <investigator>
      <last_name>Ovunc Bardakcioglu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Brooks, RPA-C</last_name>
      <phone>214-420-4732</phone>
      <email>vbrooks@chpnet.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Martz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Munger</last_name>
      <email>Jordan.Munger@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Joel Bauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Gendics</last_name>
      <email>Cynthia.gendics@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Mitchell Bernstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koiana Trencheva</last_name>
      <email>kivanova@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Toyooki Sonoda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnatti</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marla Prues, RN, OCN</last_name>
      <email>marla.prues@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Ian Paquette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Wiley-Wade, RN</last_name>
      <email>WILEYWC@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Emre Gorgun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Seafler, RN</last_name>
      <email>christina.seafler@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Scott Steele, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Allawi</last_name>
      <email>allawi@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Virgilio George, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cody Brooke</last_name>
      <email>cody.r.brooke@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Timothy Geiger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leticia Torres, RN</last_name>
      <email>Leticia.Torres@BSWHealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Tammy Fisher, RN,MBA,ACHE</last_name>
      <phone>214-820-2404</phone>
      <email>Tammy.Fisher@BSWHealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>James Fleshman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Ibarra</last_name>
      <email>sibarra@houstoncolon.com</email>
    </contact>
    <investigator>
      <last_name>Eric Haas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>March 10, 2017</lastchanged_date>
  <firstreceived_date>July 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rectal cancer</keyword>
  <keyword>Rectal neoplasm</keyword>
  <keyword>Colorectal surgery</keyword>
  <keyword>Anastomosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
